These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 18606604)
1. Safety and efficacy of long-term treatment with linezolid in cystic fibrosis: case report. Spicuzza L; Sciuto C; La Rosa M J Chemother; 2008 Jun; 20(3):399-401. PubMed ID: 18606604 [No Abstract] [Full Text] [Related]
2. Successful treatment of methicillin-resistant Staphylococcus aureus pulmonary infection with linezolid in a patient with cystic fibrosis. Ferrin M; Zuckerman JB; Meagher A; Blumberg EA Pediatr Pulmonol; 2002 Mar; 33(3):221-3. PubMed ID: 11836802 [TBL] [Abstract][Full Text] [Related]
3. Is linezolid superior to vancomycin for complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus? Kalil AC; Puumala S; Stoner J Antimicrob Agents Chemother; 2006 May; 50(5):1910; author reply 1910-1. PubMed ID: 16641477 [No Abstract] [Full Text] [Related]
4. Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosis. Gales AC; Sader HS; Andrade SS; Lutz L; Machado A; Barth AL Int J Antimicrob Agents; 2006 Apr; 27(4):300-2. PubMed ID: 16527459 [TBL] [Abstract][Full Text] [Related]
5. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Stevens DL; Herr D; Lampiris H; Hunt JL; Batts DH; Hafkin B Clin Infect Dis; 2002 Jun; 34(11):1481-90. PubMed ID: 12015695 [TBL] [Abstract][Full Text] [Related]
6. Linezolid use in sepsis due to methicillin-susceptible Staphylococcus aureus. De Gascun C; Rajan L; O'Neill E; Smyth EG J Antimicrob Chemother; 2006 Jan; 57(1):150-1. PubMed ID: 16244085 [No Abstract] [Full Text] [Related]
7. Comment on: linezolid use in sepsis due to methicillin-susceptible Staphylococcus aureus. De Beeck VO; Dhif N; Philipp J; De Bels D J Antimicrob Chemother; 2006 Mar; 57(3):577. PubMed ID: 16431858 [No Abstract] [Full Text] [Related]
8. Haematological safety of long-term therapy with linezolid. Garazzino S; De Rosa FG; Bargiacchi O; Audagnotto S; Maiello A; Di Perri G Int J Antimicrob Agents; 2007 Apr; 29(4):480-3. PubMed ID: 17317112 [No Abstract] [Full Text] [Related]
9. Occurrence of MRSA endocarditis during linezolid treatment. Ben Mansour EH; Jacob E; Monchi M; Ledoux D; Canivet JL; De Mol P; Damas P Eur J Clin Microbiol Infect Dis; 2003 Jun; 22(6):372-3. PubMed ID: 12768433 [No Abstract] [Full Text] [Related]
10. Endocarditis caused by methicillin-resistant Staphylococcus aureus: treatment failure with linezolid. Ruiz ME; Guerrero IC; Tuazon CU Clin Infect Dis; 2002 Oct; 35(8):1018-20. PubMed ID: 12355391 [TBL] [Abstract][Full Text] [Related]
11. Linezolid versus vancomycin for methicillin-resistant Staphylococcus aureus infections. Johnson JR Clin Infect Dis; 2003 Jan; 36(2):236-7. PubMed ID: 12522761 [No Abstract] [Full Text] [Related]
12. Emergence of linezolid resistance in a methicillin resistant Staphylococcus aureus strain. Hentschke M; Saager B; Horstkotte MA; Scherpe S; Wolters M; Kabisch H; Grosse R; Heisig P; Aepfelbacher M; Rohde H Infection; 2008 Feb; 36(1):85-7. PubMed ID: 18165857 [No Abstract] [Full Text] [Related]
13. Linezolid-resistant ST36 methicillin-resistant Staphylococcus aureus associated with prolonged linezolid treatment in two paediatric cystic fibrosis patients. Hill RL; Kearns AM; Nash J; North SE; Pike R; Newson T; Woodford N; Calver R; Livermore DM J Antimicrob Chemother; 2010 Mar; 65(3):442-5. PubMed ID: 20089543 [TBL] [Abstract][Full Text] [Related]
14. No mercy for MRSA: treatment alternatives to vancomycin and linezolid. Wegner DL MLO Med Lab Obs; 2005 Jan; 37(1):26-9. PubMed ID: 15743145 [No Abstract] [Full Text] [Related]
16. Relationship of linezolid minimum inhibitory concentration and time to bacterial eradication in treatment for methicillin-resistant Staphylococcus aureus infection. Moise PA; Castro RS; Sul C; Forrest A; Sakoulas G Ann Pharmacother; 2008 Apr; 42(4):592-3. PubMed ID: 18349303 [No Abstract] [Full Text] [Related]